Dermata Therapeutics Announces Exercise of Warrants for $6.2 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the ...
Morningstar22h
Invesco Diversified Dividend A
It earns an Above Average Process rating. Santoro's process focuses on stocks with steady and increasing dividends, while also looking beyond the dividend. The team examines cash flows ...